Evidence map›Paper›PMID 27720448›Full record

ArticleVaccine2016

Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study.

Tochukwu Raphael Abadom, Adrian D Smith, Stefano Tempia, Shabir A Madhi, Cheryl Cohen, Adam L Cohen

Abstract readCase Reports
In one paragraph

Article in Vaccine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Influenza and tuberculosis co-infection: A systematic review.Influenza and other respiratory viruses · 2020
    Pooled it
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Host variations in SARS-CoV-2 infection.Turkish journal of biology = Turk biyoloji dergisi · 2021
    Review
  19. Article
  20. COVID-19 and Tuberculosis.Journal of translational internal medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tochukwu Raphael AbadomNuffield Department of Population Health, University of Oxford, Oxford, England. Electronic address: abadomtochukwu@gmail.com.
Adrian D SmithNuffield Department of Population Health, University of Oxford, Oxford, England. Electronic address: adrian.smith@dph.ox.ac.uk.
Stefano TempiaInfluenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: stefanot@nicd.ac.za.
Shabir A MadhiCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa. Electronic address: ShabirM@nicd.ac.za.
Cheryl CohenCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa. Electronic address: cherylc@nicd.ac.za.
Adam L CohenInfluenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA; U.S. Public Health Service, Rockville, MD, USA; Expanded Programme on Immunization, Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland(1). Electronic address: cohena@who.int.

Funding

Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09U01IP001048 · IP · NATIONAL HEALTH LABORATORY SERVICE · PI COHEN, CHERYL · 2016 to 2020
$19.9M
South African Preparedness for Rapid Detection of Highly Pathogenic Avian InfluenU51IP000155 · IP · NATIONAL INST FOR COMMUNICABLE DISEASES · PI VENTER, MARIETJIE · 2007 to 2010
$6.7M
Sustaining Surveillance Networks and Response to Seasonal U51IP000528 · IP · NATIONAL HEALTH LABORATORY SERVICE · PI COHEN, CHERYL · 2011 to 2015
$6.1M
NCIRD CDC HHS U01 IP001048NCIRD CDC HHS U51 IP000155NCIRD CDC HHS U51 IP000528World Health Organization 001
6 · The paper itself

Abstract

backgroundInfluenza is a common cause of severe respiratory illness, but risk factors for hospitalisation in low income settings with a high HIV prevalence are not well described. We aimed to assess risk factors associated with influenza-associated severe acute respiratory illness (SARI) hospitalisation in South Africa.

methodsWe conducted a case-population study using data on risk conditions in patients hospitalised with SARI and the national prevalence of these conditions. Data on hospitalised cases were from the national SARI surveillance program while data on the referent population were from the latest national census or health and demographic surveillance surveys.

findingsFrom 2009 to 2012, we identified 3646 (7.9%) of 46,031 enrolled cases of SARI that were associated with influenza infection. Risk factors associated with hospitalisation included previous history of smoking [case-population ratio (CPR) 3.82, 95% confidence interval (CI) 3.5-4.16], HIV infection (CPR 3.61, 95% CI 3.5-3.71), asthma (CPR 2.45, 95% CI 2.19-2.73), previous history of hospital admission in the past 12months (CPR 2.07, 95% CI 1.92-2.23), and tuberculosis (CPR 1.85, 95% CI 1.68-2.02). When stratified by age, there is increased risk of hospitalisation in those ⩽5yearsof age (CPR 3.07, 95% CI 2.93-3.21) and among those 35yearsof age and above (CPR 1.23, 95% CI 1.28-1.18). Male sex (CPR 0.85, 95% CI 0.82-0.88) and completion of pneumococcal conjugate vaccination schedule in children <5yearsof age (CPR 0.74, 95% CI 0.71-0.77) were associated with decreased risk of hospitalisation.

conclusionThese results identify groups at high-risk for severe influenza who should be considered potential targets for influenza vaccination in South Africa and similar settings.

Indexed as

Population SurveillanceAcute DiseaseAdolescentAdultAgedAsthmaChildFemaleHIV InfectionsHospitalizationHumansInfluenza, HumanInfluenza VaccinesMaleMiddle AgedPneumococcal VaccinesInfluenza VaccinesPneumococcal VaccinesHospitalisationInfluenzaRisk factorsVaccine

Identifiers

PMID27720448
PMCPMC5714809

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.